http://www.reuters.com/article/companyNewsAndPR/idUSN2639625620080127CHICAGO (Reuters) - New York Attorney General Andrew Cuomo has subpoenaed Merck & Co and Schering-Plough Corp for documents and information to see whether the companies hid the results of a study on their cholesterol drug Vytorin.
The move, announced on Saturday, came one day after U.S. regulators said they would review
the study, called Enhance, which showed Vytorin worked no better than a generic in preventing the build-up of arterial plaque.
The U.S. Food and Drug Administration said it was not advising doctors to stop prescribing Vytorin, but shares of the two companies fell on Friday as news of the review unnerved investors. The two stocks have fallen more than 20 percent since the results of the study were released on January 14, triggering a debate over Vytorin's value.
Cuomo said the investigation would review the marketing of Vytorin and also the sale of the companies' stocks to investors before the study's negative results were disclosed.
snip
Printer-friendly format
Email this thread to a friend
Bookmark this thread
(1000+ posts)
Send PM |
Profile |
Ignore